Mean (SD) proportion of prescription per 100 patients at T2 | Change from baseline in Mean (SD) proportion of prescription per 100 patients at T2 | ||||
---|---|---|---|---|---|
Fact box | Simulation | Fact box | Simulation | p* Baseline adjusted mean difference [95% CI] | |
General practitioners | (n = 110) | (n = 104) | (n = 110) | (n = 104) | |
Strong opioids | 20.8 (9.4) | 18.3 (9.2) | – 2.2 (5.1) | – 3.9 (6.3) | 0.006* –1.89 [– 3.22; – 0.55] |
Nonsteriod anti-inflammatory drugs (NSAID) | 83.8 (15.4) | 88.5 (11.6) | – 1.0 (3.5) | 0.9 (6.8) | 0.001* 2.24 [0.9; 3.58] |
Weak opioids | 13.7 (10.5) | 9.7 (9.1) | 1.4 (4.6) | – 3.8 (7.4) | < 0.001* – 4.89 [– 6.4; – 3.39] |
Multimodal therapy | 17.9 (13.0) | 17.3 (13.8) | – 0.2 (3.6) | 0.5 (2.5) | 0.129 0.65 [–0.19;1.48] |
Physiotherapy, endurance sports | 68.2 (21.4) | 68.2 (21.2) | 1.0 (5.6) | 0.2 (3.3) | 0.239 – 0.71 [–1.91; 0.48] |
Psychotherapy | 29.5 (23.8) | 30.0 (22.8) | – 0.4 (3.6) | 0.9 (2.9) | 0.005* 1.24 [- 0.38; 2.1] |
Means of opioid reduction | 27.0 (22.6) | 28.0 (22.1) | – 0.4 (5.4) | 1.9 (4.5) | 0.001* 2.3 [– 0.97; 3.63] |
Pain specialists | (n = 99) | (n = 113) | (n = 99) | (n = 113) | |
Strong opioids | 25.3 (11.5) | 22.5 (11.1) | – 1.4 (3.8) | – 3.3 (5.4) | 0.002* –1.98 [– 3.2; –0.762] |
Nonsteriod anti-inflammatory drugs (NSAID) | 76.5 (20.2) § | 80.8 (18.4) § | – 1.2 (4.0) § | – 0.3 (4.9) § | 0.080 1.01 [– 0.12: 2.13] |
Weak opioids | 16.8 (12.6) | 12.6 (10.3) | 0.6 (6.5) | – 2.3 (6.7) | < 0.001* – 3.19 [– 4.82; –1.56] |
Multimodal therapy | 27.7 (16.7) | 26.2 (16.8) | – 0.5 (2.7) | 0.1 (4.2) | 0.393 0.41 [– 0.54;1.37] |
Physiotherapy, endurance sports | 66.0 (18.6) | 65.2 (19.1) | 1.1 (4.9) | 1.1 (4.2) | 0.715 0.23 [– 1;1.45] |
Psychotherapy | 50.6 (30.6) | 44.3 (30.1) | 0.2 (3.3) | 0.2 (3.6) | 0.584 – 0.25 [– 1.16; 0.66] |
Means of opioid reduction | 42.2 (30.2) § | 43.5 (29.8) § | – 0.6 (7.3) § | 6.5 (14.2) § | < 0.001* 6.41 [3.35; 9.48] |